[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341153-105":59,"doc-detail-341153-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","synthetic-biology-approaches-for-improving-the-specificity-and-efficacy-of-cancer-immunotherapy","Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy","","Immunotherapy has demonstrated strong efficacy across many hematologic and solid malignancies, yet key limitations remain. Major challenges include on-target off-tumor toxicity, systemic toxicity, and difficulty achieving potent, durable therapeutic activity. Synthetic biology is highlighted as a promising engineering framework to build living cells with customized functions, improving specificity, controllability, and efficacy. The review surveys current advances and future directions, focusing on two strategies: engineered immune cells targeting tumor surface antigens and engineered gene circuits detecting intratumoral disease signatures.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/synthetic-biology-approaches-for-improving-the-specificity-and-efficacy-of-cancer-immunotherapy/341153/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/synthetic-biology-approaches-for-improving-the-specificity-and-efficacy-of-cancer-immunotherapy/341153.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are the main safety and efficacy challenges in cancer immunotherapy discussed in the review?","Question",{"text":112,"@type":113},"The review emphasizes on-target off-tumor toxicity, systemic toxicity, and the complexity of achieving potent and sustained therapeutic efficacy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the review describe the role of synthetic biology in improving cancer immunotherapy?",{"text":117,"@type":113},"Synthetic biology provides tools to engineer living cells with customized functions, aiming to enhance specificity, controllability, and efficacy.",{"name":119,"@type":110,"acceptedAnswer":120},"What two principal synthetic biology strategies does the review focus on?",{"text":121,"@type":113},"It focuses on engineered immune cells that target tumor surface antigens and engineered gene circuits that detect intratumoral disease signatures.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341153,1790127560,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/cmi](www.nature.com/cmi)  \nREVIEW ARTICLE OPEN   \nSynthetic biology approaches for improving the speciﬁcity andefﬁcacy of cancer immunotherapy  \nBo Zhu1,6 ✉, Hang Yin2,3,6, Di Zhang4, Meiling Zhang5, Xiaojuan Chao 1, Luca Scimeca2,3 and Ming-Ru Wu 2,3 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n| Immunotherapy has shown robust efﬁcacy in treating a broad spectrum of hematological and solid cancers. Despite the transformative impact of immunotherapy on cancer treatment, several outstanding challenges remain. These challenges include on-target off-tumor toxicity, systemic toxicity, and the complexity of achieving potent and sustainable therapeutic efﬁcacy. Synthetic biology has emerged as a promising approach to overcome these obstacles, offering innovative tools for engineering living cells with customized functions. This review provides an overview of the current landscape and future prospects of cancer immunotherapy, particularly emphasizing the role of synthetic biology in augmenting its speciﬁcity, controllability, and efﬁcacy. We delineate and discuss two principal synthetic biology strategies: those targeting tumor surface antigens with engineered immune cells and those detecting intratumoral disease signatures with engineered gene circuits. This review concludes with a forwardlooking perspective on the enduring challenges in cancer immunotherapy and the potential breakthroughs that synthetic biology may contribute to the ﬁeld. |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n\n\n|  |  |  |\n| --- | --- | --- |\n|  |  |  |\n|  | . |  |\n|  |  |  |\n|  |  |  |\n|  | Cellular & Molecular Immunology (2024) 21:436–447; [https://doi.org/10.1038/s41423-024-01](https://doi.org/10.1038/s41423-024-01)153-x |  |\n|  |  |  |\n\nkeywords: Synthetic biology; Cancer immunotherapy; Gene circuit; Gene therapy; Adoptive cell therapy  \nINTRODUCTION  \nA fundamental challenge in cancer therapies is to distinguish tumor cells from normal cells and target the detected tumor cells speciﬁcally. As tumor cells usually bear foreign (altered-self) antigens due to somatic mutations and immune cells can precisely target foreign antigens, the immune system can be harnessed to target cancer cells more speciﬁcally than traditional therapies that target less speciﬁc tumor signatures (e.g., chemotherapy targeting proliferation markers) . The history of leveraging the immune system to treat cancer can be traced back to as early as 1891, when Dr. William Bradley Coley ﬁrst attempted to actively trigger antitumor immune responses through intratumoral injections of inactivated bacteria, known as Coley’s toxins [1] . However, Coley’s toxins were not widely acknowledged at that time due to unclear mechanisms of action and the fear of the potential risks associated with pathogenic bacteria. After over a century of development, immunotherapy has revolutionized the ﬁeld of cancer treatment, drawing considerable attention to its unique advantages over conventional approaches. Currently, a wide spectrum of immunotherapeutic strategies have been tested in clinical trials, and they have changed the landscape of cancer treatment. A milestone in cancer immunotherapy was the Food and Drug Administration (FDA) approval of the checkpoint inhibitor ipilimumab, a monoclonal antibody targeting cytotoxic T lymphocyte antigen 4 (CTLA-4) in 2011 [2], which paved the way for other  \nimmunotherapeutic strategies, such as the use of monoclonal antibodies targeting programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) [3]. These checkpoint inhibitors work by blocking the interaction between PD-1 on T cells and PD-L1 on tumor cells, allowing the immune system to attack cancer cells more effectively. In addition to checkpoint inhibitors, the FDA has also approved chimeric antigen receptor (CAR)-T-cell therapies [4–6] . This type of therapy involves genetically modifying a patient’s T cells to express a CAR that targets a speciﬁc antigen on the surfac","cbCaiplVs2nsBL2G","https://ap.wps.com/l/cbCaiplVs2nsBL2G","pdf",1058650,12,"English","# Introduction\n## Immunotherapy background and clinical milestones\n## Targeting specificity and safety challenges\n# Synthetic biology strategies in cancer immunotherapy\n## Engineered immune cells for tumor surface antigens\n## Engineered gene circuits for intratumoral disease signatures\n# Future perspectives and concluding outlook","[{\"question\":\"What are the main safety and efficacy challenges in cancer immunotherapy discussed in the review?\",\"answer\":\"The review emphasizes on-target off-tumor toxicity, systemic toxicity, and the complexity of achieving potent and sustained therapeutic efficacy.\"},{\"question\":\"How does the review describe the role of synthetic biology in improving cancer immunotherapy?\",\"answer\":\"Synthetic biology provides tools to engineer living cells with customized functions, aiming to enhance specificity, controllability, and efficacy.\"},{\"question\":\"What two principal synthetic biology strategies does the review focus on?\",\"answer\":\"It focuses on engineered immune cells that target tumor surface antigens and engineered gene circuits that detect intratumoral disease signatures.\"}]","Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy | PDF",1790040579,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3db543dcd7c1b814ce7cfe10535f57b.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f4a52a72491f81d77087b4a7aed7546.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd427e1279d19412791283681330cbb4.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65bc5132cb23038944ede6985bc37de3.webp",980,1301]